Corbus(CRBP)

首次持股声明

Corbus(CRBP)03-01 06:15

$Corbus制药控股(CRBP)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-24-004119  Size: 6 KB 网页链接查看全文

超过5%股东持股披露

Corbus(CRBP)02-29 06:05

$Corbus制药控股(CRBP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001273087-24-000053  Act: 34  Size: 81 KB 网页链接查看全文

超过5%股东持股披露

Corbus(CRBP)02-06 05:55

$Corbus制药控股(CRBP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000929638-24-000374  Act: 34  Size: 110 KB 网页链接查看全文

当期报告

Corbus(CRBP)02-05 21:15

$Corbus制药控股(CRBP)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0000950170-24-011013  Act: 34  Size: 29 MB 网页链接查看全文

当期报告

Corbus(CRBP)03-21 05:15

$Corbus制药控股(CRBP)$ 8-K Current report, item 8.01 Accession Number: 0000950170-24-034271  Act: 34  Size: 148 KB 网页链接查看全文

股东委托书协议

Corbus(CRBP)04-03 04:35

$Corbus(CRBP)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-040242  Act: 34  Size: 2 MB 网页链接查看全文

超过5%股东持股披露

Corbus(CRBP)02-15 05:15

$Corbus制药控股(CRBP)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023629  Act: 34  Size: 68 KB 网页链接查看全文

超过5%股东持股披露「修订」

Corbus(CRBP)02-15 05:55

$Corbus制药控股(CRBP)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001140361-24-008026  Act: 34  Size: 122 KB 网页链接查看全文

招股说明书

Corbus(CRBP)02-02 06:15

$Corbus制药控股(CRBP)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0000950170-24-009865  Act: 33  Size: 850 KB 网页链接查看全文

当期报告

Corbus(CRBP)02-02 06:35

$Corbus制药控股(CRBP)$ 8-K Current report, items 1.01, 7.01, and 9.01 Accession Number: 0000950170-24-009874  Act: 34  Size: 668 KB 网页链接查看全文

石药集团巨石生物独家授权Corbus的SYS6002第一阶段临床试验数据取得积极进展

股界一粒沙01-27 02:24

$Corbus制药控股(CRBP)$ $新诺威(SZ300765)$ $石药集团(01093)$
Corbus数据公布后股价暴涨，截止发帖时间已经上涨3倍多。
近日，石药集团/Corbus在2024年(ASCO-GU2024)上，公布了靶向nectin-4抗体药物偶联物（ADC）SYS6002的I期剂量递增数据。
具体数据可以查询Corbus发布的公告...查看全文

产业链观察01-26 22:41

$Corbus制药控股(CRBP)$ 今天介绍新的下一代nectin-4#ADC药物# 的早期ADC数据。股价翻倍。查看全文

Honey62023-12-30 10:26

$Corbus制药控股(CRBP)$ 小盘妖股看看就好查看全文

牛唐2023-03-17 17:31

医药板块速评（2023.03.16）
1、大盘反弹，是继续看多，还是做空良机？
2、$Corbus制药控股(CRBP)、$Elevation Oncology(ELEV)三天翻倍，背后逻辑是什么，谁有潜力成为下一个？
3、$中概互联网指数ETF-KraneShares(KWEB)、$英特尔(INTC)$ 、$台积电(TSM)期权大量成交，后续走势如何看...查看全文

chuminhua2021-06-27 22:45

6月25日，对于Corbus制药公司和自身免疫性疾病治疗药物lenabasum来说，情况并不乐观。
Corbus公司披露了这种合成口服大麻素2型激动剂的一长串失败案例，这次是在罕见的自身免疫性疾病皮肌炎的后期试验中。
早在9月，Corbus公司透露，lenabasum在皮肤系统性硬化症的3期试验中失败，另一项中...查看全文

First-in-class: Synendos将A轮融资规模扩大至2400万瑞郎

andrewmed2021-04-21 09:22

文章来源：“凯莱英药闻”微信公众号
4月20日，瑞士创新药企业Synendos Therapeutics宣布延长A轮融资，新加入投资方Ysios Capital，将融资规模扩大至2400万瑞郎。Synendos于2020年11月开启A轮融资，由Kurma Partners和Sunstone Life Science Ventures共同投资，规模为2000万瑞郎。
该笔融...查看全文

lovetc0032021-02-23 23:02

$Corbus制药控股(CRBP)$ 真的买点原始股+2.5call，下月的~查看全文

lovetc0032021-02-23 22:28

$Corbus制药控股(CRBP)$ 工业大麻类别跌的这么厉害？？开始准备观察观察了~~虽然还是觉得电影比较有前途最近。。查看全文

翻倍的n次方哦2021-02-12 23:35

$Corbus制药控股(CRBP)$ 这个点位继续接回来了罗，3.11哈哈，看来昨天清仓卖对了查看全文

嘻嘻嘻周的美国之旅2021-02-11 21:36

$Corbus制药控股(CRBP)$ 崩盘都慢了整整一拍吗？查看全文

$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-11-10 AccNo: 0001564590-15-010364 Size: 4 MB 网页链接

$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-07-21 AccNo: 0001193125-15-258365 Size: 34 KB 网页链接

$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-08-05 AccNo: 0001144204-15-046381 Size: 92 KB 网页链接

$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-07-29 AccNo: 0001144204-15-044904 Size: 82 KB 网页链接

$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ CT ORDER - Confidential treatment order Filed: 2015-06-18 AccNo: 9999999997-15-010948 Size: 13 KB 网页链接

$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 8-K - Current report Filed: 2015-08-27 AccNo: 0001193125-15-303926 Size: 26 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 8-K - Current report Filed: 2015-08-13 AccNo: 0001193125-15-289028 Size: 82 KBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 8-K - Current report Filed: 2015-07-27 AccNo: 0001193125-15-264114 Size: 50 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 8-K - Current report Filed: 2015-05-29 AccNo: 0001193125-15-206775 Size: 19 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接

$CORBUS PHARMACEUTICALS HLDGS(CRBP)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2015-08-13 AccNo: 0001193125-15-289174 Size: 410 KB 网页链接